IL25 and graft versus host disease: Furthermore, goblet cell expansion using IL-25 did not ameliorate GVHD in LYPD8-deficient recipients, suggesting that the mucus layer containing LYPD8 is critical for goblet cell-mediated GVHD suppression (2).